FBKFX
Price
$16.76
Change
+$0.02 (+0.12%)
Updated
Jul 18 closing price
Net Assets
2.25B
RLBCX
Price
$36.62
Change
-$0.03 (-0.08%)
Updated
Jul 18 closing price
Net Assets
252.16B
Interact to see
Advertisement

FBKFX vs RLBCX

Header iconFBKFX vs RLBCX Comparison
Open Charts FBKFX vs RLBCXBanner chart's image
Fidelity Balanced K6
Price$16.76
Change+$0.02 (+0.12%)
VolumeN/A
Net Assets2.25B
American Funds American Balanced R3
Price$36.62
Change-$0.03 (-0.08%)
VolumeN/A
Net Assets252.16B
FBKFX vs RLBCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FBKFX vs. RLBCX commentary
Jul 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FBKFX is a Buy and RLBCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBCX has more cash in the bank: 252B vs. FBKFX (2.25B). FBKFX pays higher dividends than RLBCX: FBKFX (1.84) vs RLBCX (1.57). FBKFX was incepted earlier than RLBCX: FBKFX (6 years) vs RLBCX (23 years). RLBCX (0.89) is less costly to investors than FBKFX (0.32). RLBCX is a more actively managed with annual turnover of: 44.00 vs. FBKFX (25.00). FBKFX has a lower initial minimum investment than RLBCX: FBKFX (0) vs RLBCX (250). FBKFX annual gain was more profitable for investors over the last year : 9.74 vs. RLBCX (7.12). FBKFX return over 5 years is better than : 57.81 vs. RLBCX (37.00).
FBKFXRLBCXFBKFX / RLBCX
Total Expense Ratio0.320.8936%
Annual Report Gross Expense Ratio0.320.8936%
Fund Existence6 years23 years-
Gain YTD6.0487.85877%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets2.25B252B1%
Annual Yield % from dividends1.841.57118%
Returns for 1 year9.747.12137%
Returns for 3 years41.8032.82127%
Returns for 5 years57.8137.00156%
Returns for 10 yearsN/A59.46-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CNO37.690.09
+0.24%
CNO Financial Group
IBIO0.73N/A
+0.14%
iBio
ALOT11.22-0.06
-0.53%
AstroNova
TSHA2.57-0.02
-0.77%
Taysha Gene Therapies
CE57.31-1.19
-2.03%
Celanese Corp